Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance

The presence of barriers, such as the blood–brain barrier (BBB) and brain–tumor barrier (BTB), limits the penetration of antineoplastic drugs into the brain, resulting in poor response to treatments. Many techniques have been developed to overcome the presence of these barriers, including direct inj...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Francesca, Pellerino, Alessia, Soffietti, Riccardo, Rudà, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657947/
https://www.ncbi.nlm.nih.gov/pubmed/34884457
http://dx.doi.org/10.3390/ijms222312654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657947/
https://www.ncbi.nlm.nih.gov/pubmed/34884457
http://dx.doi.org/10.3390/ijms222312654

Ejemplares similares